Brief: Isofol Medical CFO To Leave Company
June 12 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* CHIEF FINANCIAL OFFICER TO LEAVE COMPANY
* ANNOUNCES TODAY THAT MAGNUS HURST, CFO, IS LEAVING COMPANY AT BEGINNING OF SEPTEMBER FOR
FAMILY
REASONS
* MAGNUS WILL CONTINUE IN HIS ROLE AS CFO UNTIL SEPTEMBER 2, 2024
Source text for Eikon: ID:nMFN9P3f7Z
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism